Food Intake Response to Short-Term Modifications of Metabolism in Humans
NCT ID: NCT02939404
Last Updated: 2025-07-04
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
54 participants
INTERVENTIONAL
2017-04-27
2024-06-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objectives:
To see how much food a person eats when the body's temperature is cooled. To study how changes in metabolism may alter the amount of food a person eats.
Eligibility:
Healthy people ages 18-55.
Design:
Participants will stay at NIH for 20 days.
During the first 4 days, participants will have:
* Medical exam
* Electrocardiogram
* Blood and urine tests. One blood test includes drinking a sugar solution.
* DXA body composition scan
* Questions about foods they like, physical activity, and personal behavior
* Exercise test on a stationary bicycle
Participants will spend 24-hour periods in a metabolic chamber. The chamber will be at normal room temperature or cooler.
Some times, participants will eat a diet that matches their daily needs (fixed or eucaloric). Other times, they can eat as much as they wish from a vending machine (ad libitum).
Participants will have blood and urine collected.
Participants will swallow an ingestible wireless sensor and wear a small data recorder device.
On the second to last day, participants will stay in the metabolic chamber but only consume water and non-caffeinated sugar-free beverages.
Participants will come back for 1-day visits at six months and one year from the first admission. They will have blood and urine tests, and a DXA scan. They will answer questions on physical activity and food habits.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Diet Changes on Metabolism
NCT00523627
The Effects of Increasing Caloric Intake on Diet-Induced Thermogenesis and 24h Energy Expenditure
NCT05545306
Alternating Energy Intake and Blood Fat Content After a Meal
NCT04894526
Metabolism and Thyroid Hormone Changes During Exposure to Cold Temperatures
NCT00521729
ChronoMet: Metabolic and Inflammatory Effects of Eating Timing and Quantity
NCT06161337
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1. Chamber at 24C, fixed diet
Chamber at room temperature (24C) with a fixed eucaloric diet
Normal temperature
23.25 hours inside respiratory chamber with the temperature set to 24°C
Fixed diet
A diet that matches the participant's caloric needs
2. Chamber at 24C, ad libitum diet
Chamber at room temperature (24C) with an ad libitum diet (self-select how much food they wish to eat)
Normal temperature
23.25 hours inside respiratory chamber with the temperature set to 24°C
Ad libitum diet
Participants can eat as much as they want
3. Chamber at 19C, fixed diet
Chamber at cold temperature (16C) with a fixed eucaloric diet
Cold exposure
23.25 hours inside respiratory chamber with the temperature set to19°C
Fixed diet
A diet that matches the participant's caloric needs
4. Chamber at 19C, ad libitum diet
Chamber at cold temperature (19C) with an ad libitum diet (self-select how much food they wish to eat)
Cold exposure
23.25 hours inside respiratory chamber with the temperature set to19°C
Ad libitum diet
Participants can eat as much as they want
5. Chamber at 24C, fasting
Chamber at room temperature (24C) fasting while in chamber and 12 hours before
Normal temperature
23.25 hours inside respiratory chamber with the temperature set to 24°C
Fasting
Participants do not eat for 12 hours before and 24 hours in chamber
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cold exposure
23.25 hours inside respiratory chamber with the temperature set to19°C
Normal temperature
23.25 hours inside respiratory chamber with the temperature set to 24°C
Fixed diet
A diet that matches the participant's caloric needs
Ad libitum diet
Participants can eat as much as they want
Fasting
Participants do not eat for 12 hours before and 24 hours in chamber
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body weight \<204 kg (\<450 pounds) and \>= 36 kg (\>= 80 pounds)
* Stable weight (+/-5% within past 6 months) as determined by volunteer report
* Healthy, as determined by medical history, physical examination, and laboratory tests
Exclusion Criteria
* Weight greater than or equal to 204 kg (greater than or equal to 450 pounds, maximum weight of the iDXA machine as per manufacturer s manual), or weight \<36 kg (\<80 pounds, minimum weight allowed based on the NIH guidelines of blood drawing for research purposes)
* Use of medications affecting metabolism and appetite in the last three months
* Expresses unwillingness to consume all food given during the weight maintaining diet portions of the study (e.g., due to strict dietary restrictions including allergies or vegetarian or kosher diet)
* Current use of tobacco products, marijuana, amphetamines, cocaine, or intravenous drug use
* Current pregnancy, pregnancy within the past 6 months or lactation
* History or clinical manifestation of:
* Type 1 and Type 2 diabetes mellitus
* History of surgery for the treatment of obesity
* Endocrine disorders, such as Cushing s disease, pituitary disorders, and hypo and hyperthyroidism
* Pulmonary disorders, including chronic obstructive pulmonary disease
* Cardiovascular diseases, including coronary heart disease, heart failure, arrhythmias, and peripheral artery disease
* High blood pressure by sitting blood pressure measurement using an appropriate cuff higher than 140/90 mmHg on two or more occasions, or current antihypertensive therapy
* Liver disease, including cirrhosis, active hepatitis B or C, and AST or ALT greater than or equal to 2x normal
* Gastrointestinal disease including Crohn s disease, ulcerative colitis, celiac disease or other malabsorptive disorders
* Abnormal kidney function (eGFR \<60 mL/min/1.73m(2))
* Central nervous system disease, including previous history of cerebrovascular accidents, dementia, neurodegenerative disorders or history of severe head trauma
* Cancer requiring treatment in the past five years, except for nonmelanoma skin cancers or cancers that have clearly been cured
* Infectious disease such as active tuberculosis, HIV (by self report), chronic coccidiomycoses or other chronic infections that might influence EE and weight
* Diagnosis of binge eating disorder, anorexia and major psychiatric disorders based upon the DSM-IV including depression, schizophrenia and psychosis, which may impact the ability of the participant to be in the respiratory chamber for 24 hour time periods
* Chronic ethanol use (more than 3 drinks/day)
18 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Douglas Chang, M.D.
Role: PRINCIPAL_INVESTIGATOR
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
NIDDK, Phoenix
Phoenix, Arizona, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Unlu Y, Piaggi P, Stinson EJ, De Baca TC, Rodzevik TL, Walter M, Fry H, Krakoff J, Chang DC. Cold induces increased ad libitum energy intake independent of changes in energy expenditure: a controlled crossover trial in adults. Am J Clin Nutr. 2025 Feb;121(2):293-303. doi: 10.1016/j.ajcnut.2024.12.013. Epub 2024 Dec 14.
Hollstein T, Heinitz S, Ando T, Rodzevik TL, Basolo A, Walter M, Chang DC, Krakoff J, Piaggi P. Metabolic Responses to 24-Hour Fasting and Mild Cold Exposure in Overweight Individuals Are Correlated and Accompanied by Changes in FGF21 Concentration. Diabetes. 2020 Jul;69(7):1382-1388. doi: 10.2337/db20-0153. Epub 2020 Apr 27.
Hollstein T, Basolo A, Ando T, Votruba SB, Walter M, Krakoff J, Piaggi P. Recharacterizing the Metabolic State of Energy Balance in Thrifty and Spendthrift Phenotypes. J Clin Endocrinol Metab. 2020 May 1;105(5):1375-92. doi: 10.1210/clinem/dgaa098.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17-DK-N004
Identifier Type: OTHER
Identifier Source: secondary_id
999917004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.